Showing results (851-860 of 873) with videos related to
Sort By:
Pageof 88
Actas Urologicas Espanolas|November 1, 2024
Efficacy and safety of Optilume® paclitaxel-coated urethral dilatation balloon in real-life: experience in a Spanish multicenter studyC Ballesteros Ruiz, F Campos-Juanatey, I Povo Martín, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 6, 2022
Natural history of TANGO2 deficiency disorder: Baseline assessment of 73 patientsChristina Y Miyake, Erica J Lay, Claudia Soler-Alfonso, et al.JAMA Cardiology|January 31, 2024
Familial Hypercholesterolemia Variant and Cardiovascular Risk in Individuals With Elevated CholesterolYiyi Zhang, Jacqueline S Dron, Brandon K Bellows, et al.Cancer Discovery|December 9, 2024
Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate CancerLisa N Chesner, Fanny Polesso, Julie N Graff, et al.American Journal of Hypertension|April 22, 2026
Evidence-Informed Prioritization of Interventions for Integrating Hypertension Management into Cardiovascular-Kidney-Metabolic Care in Primary Health Care: HEARTS 2.0 Phase 3Pedro Ordunez, Andres Rosende, Maria Florencia Grande Ratti, et al.The Journal of Infectious Diseases|April 27, 2026
Effects of age and birth cohort on influenza A virus subtype-specific hospitalization rates, United States 2010-2025Alissa O'Halloran, Nicole Hood, Dawud Ujamaa, et al.Circulation|January 30, 2020
Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart AssociationSalim S Virani, Alvaro Alonso, Emelia J Benjamin, et al.The New England Journal of Medicine|January 31, 2019
Oral versus Intravenous Antibiotics for Bone and Joint InfectionHo-Kwong Li, Ines Rombach, Rhea Zambellas, et al.Journal of the American College of Cardiology|December 14, 2020
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 StudyGregory A Roth, George A Mensah, Catherine O Johnson, et al.Nature|June 15, 2022
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapyChristopher P Vellano, Michael G White, Miles C Andrews, et al.Pageof 88